Inhibrx Biosciences, Inc. (INBX) earnings
Quarterly results of Inhibrx Biosciences, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Inhibrx Biosciences, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Inhibrx Biosciences, Inc. reported revenue of $0 and a net loss of $36.7M.
Diluted earnings per share were -$2.34.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $0 | - | -$36.7M | -$2.34 |
| Q1 FY2026 | - | - | -$33.4M | -$2.15 |
| Q4 FY2025 | $0 | - | -$32.8M | - |
| Q3 FY2025 | $0 | - | -$35.3M | -$2.28 |
| Q2 FY2025 | $1.3M | - | -$28.7M | -$1.85 |
| Q1 FY2025 | $0 | - | -$43.3M | -$2.80 |
| Q4 FY2024 | $100K | - | -$47.9M | - |
| Q3 FY2024 | $0 | - | -$43.9M | -$2.84 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
When is Inhibrx Biosciences, Inc.'s next earnings date?
Inhibrx Biosciences, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Inhibrx Biosciences, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Inhibrx Biosciences, Inc. reported revenue of $0 and a net loss of $36.7M. The figures come from its filing with the SEC.
Get an email when INBX reports
Follow INBX and we email you its next results the day they are filed, with the numbers explained.